Taking the aforementioned limitations into account, there is an emerging need for additional multicenter larger-scale studies performing serial copeptin testing following stroke, in order to investigate whether copeptin evaluation further enhances the risk stratification of stroke survivors. Here, AVP is linked to Stroke.